Janet Woodcock, M.D.

Janet Woodcock served as the Acting Commissioner of the U.S. Food and Drug Administration from January 20, 2021, until February 17, 2022. Dr. Woodcock began her FDA career in 1986 at the Center for Biologics Evaluation and Research (CBER). At CBER, she served as Director of the Division of Biological Investigational New Drugs and as Acting Deputy Director. She is widely regarded as one of the foremost pioneers in personalized medicine.